comparemela.com

Latest Breaking News On - Adjunct professorships - Page 1 : comparemela.com

Combined position as Associate Professor II/Researcher or Professor II/Senior Researcher job with Institute for Experimental Medical Research

Combined position as Associate Professor II/Researcher or Professor II/Senior Researcher job in Oslo, Norway with Institute for Experimental Medical Research. Apply Today.

Tverfjell
Søøag
Norway
Oslo
Norwegian
Mathis-korseberg-stokke
University-of-oslo-ui
South-eastern-norway-regional-health-authority
Institute-head
Institute-for-experimental-medical-research
Institute-of-clinical-medicine
Head-of-department

Nancy S. Jecker

Consultant/Associate Professor till Lovisenberg Diakonale Sykehus, Oslo

Lovisenberg Diakonale Sykehus, Oslo Ansök nu Senior Consultant combined with Adjunct Professor/ Associate Professor (20 %) in medicine (Orthopaedic Surgery) Lovisenberg Diaconal Sykehus AS (LDS) is a hospital for approximately 200,000 inhabitants in Oslo in the field of internal medicine and mental health care. Furthermore the hospital has extensive elective surgery activity with 9000 operations per year in the field of orthopaedic, ENT and General surgery. The hospital is owned by the diaconal foundations Diakonova and Diakonissehuset Lovisenberg, and has an operating agreement with South-Eastern Norway Regional Health Authority (HSØ RHF). The hospital is based on diaconal values with non-commercial purposes. You as an employee are expected to actively contribute to our core values of quality and charity. See www.lds.no 

Norway
Oslo
Norwegian
Lars-vasli
Diakonissehuset-lovisenberg
Heidi-falch-ecklund
Anners-lerdal
Department-for-quality
Research-department-at-lovisenberg-diaconal-hospital
Institute-of-clinical-medicine
South-eastern-norway-regional-health-authority
University-of-oslo-ui

Athersys Announces CEO Transition

Press release content from Business Wire. The AP news staff was not involved in its creation. Athersys Announces CEO Transition CLEVELAND, Ohio (BUSINESS WIRE) Feb 16, 2021 Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem ® cell therapy, today announced that Dr. Gil Van Bokkelen has stepped down as Chairman and Chief Executive Officer, effective immediately. The Athersys Board has appointed William (B.J.) Lehmann, the Company’s President and Chief Operating Officer, as Interim Chief Executive Officer. Dr. Ismail Kola, Lead Director of the Athersys Board, has been appointed Chairman of the Board. The Company’s Board is commencing a comprehensive search process to identify a permanent CEO. The Board intends to identify and select a CEO who can guide Athersys in the commercial stage.

Japan
Australia
University-of-chicago
Illinois
United-states
United-kingdom
Missouri
Texas
University-of-cape-town
Western-cape
South-africa
Washington-university

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.